The first Mirati Therapeutics trade was made in Q4 2017. Since then Steven Cohen bought shares fourteen more times and sold shares on thirteen occasions. The investor sold all their shares in Q4 2023 and doesn't own any shares in Mirati Therapeutics anymore.